| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US5919832 | COSETTE | Amine polymer sequestrant and method of cholesterol depletion |
Apr, 2014
(9 years ago) | |
| US6066678 | COSETTE | Process for removing bile salts from a patient and alkylated compositions therefor |
Apr, 2014
(9 years ago) | |
| US7101960 | COSETTE | Process for removing bile salts from a patient and alkylated compositions therefor |
Apr, 2014
(9 years ago) | |
| US5917007 | COSETTE | Process for removing bile salts from a patient and alkylated compositions therefor |
Apr, 2014
(9 years ago) | |
| US6433026 | COSETTE | Process for removing bile salts from a patient and alkylated compositions therefor |
Apr, 2014
(9 years ago) | |
| US6784254 | COSETTE | Process for removing bile salts from a patient and alkylated compositions therefor |
Apr, 2014
(9 years ago) | |
| US5693675 | COSETTE | Alkylated amine polymers |
Dec, 2014
(9 years ago) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5679717 | COSETTE | Method for removing bile salts from a patient with alkylated amine polymers |
Apr, 2014
(9 years ago) | |
| US5917007 | COSETTE | Process for removing bile salts from a patient and alkylated compositions therefor |
Apr, 2014
(9 years ago) | |
| US5607669 | COSETTE | Amine polymer sequestrant and method of cholesterol depletion |
Jun, 2014
(9 years ago) | |
| US6066678 | COSETTE | Process for removing bile salts from a patient and alkylated compositions therefor |
Jun, 2014
(9 years ago) | |
| US6433026 | COSETTE | Process for removing bile salts from a patient and alkylated compositions therefor |
Jun, 2014
(9 years ago) | |
| US5919832 | COSETTE | Amine polymer sequestrant and method of cholesterol depletion |
Jun, 2014
(9 years ago) | |
|
US7101960 (Pediatric) | COSETTE | Process for removing bile salts from a patient and alkylated compositions therefor |
Oct, 2014
(9 years ago) | |
|
US5917007 (Pediatric) | COSETTE | Process for removing bile salts from a patient and alkylated compositions therefor |
Oct, 2014
(9 years ago) | |
|
US5679717 (Pediatric) | COSETTE | Method for removing bile salts from a patient with alkylated amine polymers |
Oct, 2014
(9 years ago) | |
|
US6784254 (Pediatric) | COSETTE | Process for removing bile salts from a patient and alkylated compositions therefor |
Oct, 2014
(9 years ago) | |
| US5693675 | COSETTE | Alkylated amine polymers |
Dec, 2014
(9 years ago) | |
|
US6433026 (Pediatric) | COSETTE | Process for removing bile salts from a patient and alkylated compositions therefor |
Dec, 2014
(9 years ago) | |
|
US6066678 (Pediatric) | COSETTE | Process for removing bile salts from a patient and alkylated compositions therefor |
Dec, 2014
(9 years ago) | |
|
US5919832 (Pediatric) | COSETTE | Amine polymer sequestrant and method of cholesterol depletion |
Dec, 2014
(9 years ago) | |
|
US5607669 (Pediatric) | COSETTE | Amine polymer sequestrant and method of cholesterol depletion |
Dec, 2014
(9 years ago) | |
|
US5693675 (Pediatric) | COSETTE | Alkylated amine polymers |
Jun, 2015
(8 years ago) | |
| US7229613 | COSETTE | Method for lowering serum glucose |
Apr, 2022
(2 years ago) | |
|
US7229613 (Pediatric) | COSETTE | Method for lowering serum glucose |
Oct, 2022
(1 year, 6 months ago) | |
Welchol is owned by Cosette.
Welchol contains Colesevelam Hydrochloride.
Welchol has a total of 25 drug patents out of which 25 drug patents have expired.
Expired drug patents of Welchol are:
- US5679717
- US5917007
- US5607669
- US6066678
- US6433026
- US5919832
- US7101960*PED
- US5917007*PED
- US5679717*PED
- US6784254*PED
- US6433026*PED
- US6066678*PED
- US5919832*PED
- US5693675
- US5607669*PED
- US5693675*PED
- US7229613
- US7229613*PED
- US5919832
- US6066678
- US7101960
- US5917007
- US6433026
- US6784254
- US5693675
Welchol was authorised for market use on 02 October, 2009.
Welchol is available in tablet;oral, bar, chewable;oral, for suspension;oral, capsule;oral dosage forms.
Welchol can be used as use as a bile acid sequestrant, treatment of type 2 diabetes mellitus, use as a bile acid sequestrant for lowering cholesterol.
The generics of Welchol are possible to be released after 20 October, 2024.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-232) | Oct 20, 2024 |
| New Indication(I-608) | Oct 02, 2012 |
| Pediatric Exclusivity(PED) | Apr 02, 2013 |
Drugs and Companies using COLESEVELAM HYDROCHLORIDE ingredient
Market Authorisation Date: 02 October, 2009
Treatment: Use as a bile acid sequestrant; Use as a bile acid sequestrant for lowering cholesterol; Treatment of type 2 diabetes mellitus
Dosage: FOR SUSPENSION;ORAL; CAPSULE;ORAL; TABLET;ORAL; BAR, CHEWABLE;ORAL
WELCHOL family patents
